CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Venglustat

Phase 3
Sanofi (SNY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
2w
SNYPDUFA
Phase 3

FDA PDUFA Date Venglustat

Venglustat
Nov 25
Source
00%
Competitive Landscape

0 competitors in Gaucher's Disease Type III

View Full Landscape
Drug Information

Target Indication

Gaucher's Disease Type III

Clinical Trial

NCT05222906

Last updated: 4/18/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.